X-Linked Hyper-IgM Syndrome: CD40Ligand Deficiency (OMIM # 308230)
Author:
de la Morena M. Teresa
Publisher
Springer New York
Reference18 articles.
1. Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 1993;259:990–3.
2. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with Xlinked hyper-IgM syndrome. Cell. 1993;72:291–300.
3. Cabral-Marques O, Klaver S, Schimke LF, Ascendino EH, Khan TA, Pereira PV, et al. First report of the Hyper-IgM syndrome Registry of the Latin American Society for immunodeficiencies: novel mutations, unique infections, and outcomes. J Clin Immunol. 2014;34:146–56.
4. De la Morena MT. Clinical phenotypes of hyper IgM-syndromes. J Allergy Clin Immunol Pract. 2016;4:1023–36.
5. De la Morena MT, Leonard D, Torgerson TR, Cabral-Marques O, Slatter M, Aghamohammadi A, et al. Long-term outcomes of 178 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. J Allergy Clin Immunol. 2017;139:1282–92.